BioCentury
ARTICLE | Clinical News

Prolor preclinical data

May 17, 2010 7:00 AM UTC

In undisclosed primates, subcutaneous IFN-beta-CTP displayed 200 times the overall drug exposure of an equivalent dose of an undisclosed commercially available recombinant interferon (IFN) beta administered subcutaneously. Data were presented at the BIO International Convention in Chicago. ...